Italy - REAGENTS NEEDED FOR THE MUTATIONAL ANALYSIS OF CIRCULATING NUCLETIC ACIDS BY NGS ddPCR - PNC-E.3 PROJECT - FINANCED BY THE MINISTRY OF HEALTH UNDER THE NATIONAL PLAN FOR INVESTMENT COMPLEMENT TO THE NATIONAL RECOVERY PLAN...
For more information and to make a bid you will need to go to the third party website.
Details
Provided by
- Opportunity closing date
- 29 November 2024
- Opportunity publication date
- 21 November 2024
- Value of contract
- to be confirmed
- Your guide to exporting
Description
REAGENTS NEEDED FOR THE MUTATIONAL ANALYSIS OF CIRCULATING NUCLEIC ACIDS BY NGS ddPCR - PROJECT PNC-E.3 - FUNDED BY THE MINISTRY OF HEALTH UNDER THE NATIONAL PLAN FOR INVESTMENTS COMPLEMENTARY TO THE NATIONAL RECOVERY AND RESILIENCE PLAN, PROGRAM: INNOVATIVE HEALTH ECOSYSTEM, FOR THE RESEARCH PROJECT ENTITLED "ITALIAN NETWORK OF EXCELLENCE FOR ADVANCED DIAGNOSIS (INNOVA)", CODE PNRR13 - PNC-E3-2022-23683266 PNC-HLS-DA, CUP G13C22001570001. AFFERENT SECTOR 136213. COMPANY DIATECH PHARMACOGENETICS LTD.
- Opportunity closing date
- 29 November 2024
- Value of contract
- to be confirmed
About the buyer
- Address
- A.O.U. Città della Salute e della Scienza di Torino
Bid for tender
If your company meets the requirements of the tender, go to the website where the tender is hosted and submit your bid.
This website contains links to other websites that we do not control or maintain. We are not responsible for the content of these sites. We provide these links for your convenience only, and do not necessarily endorse their content.
Before entering into a contract you need to apply for any necessary export licences, which can include applications to trade in certain goods. You should also make your own enquiries and be satisfied by the accuracy of any information supplied to you.
This opportunity has been translated from its original language. You should check if you need to apply in the original language.